71 West Capital Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.1M Buy
5,922
+1,959
+49% +$2M 0.25% 43
2026
Q1
$3.65M Buy
3,963
+617
+18% +$626K 0.16% 49
2025
Q4
$3.6M Buy
+3,346
New +$3.2M 0.17% 50

Other funds holding LLY

71 West Capital Partners's LLY Position: Q2 2026 in Review

71 West Capital Partners increased its Eli Lilly (LLY) stake by 49% in Q2 2026, buying an estimated $2M and bringing the position to 5,922 shares worth $7.1M. The position accounts for 0.25% of the portfolio, ranked #43.

71 West Capital Partners first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,607 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • 71 West Capital Partners held 5,922 shares of Eli Lilly worth $7.1M as of Q2 2026.
  • 71 West Capital Partners bought 1,959 Eli Lilly shares in Q2 2026, an estimated $2M.
  • Eli Lilly made up 0.25% of 71 West Capital Partners's portfolio in Q2 2026, its #43 holding.
  • 71 West Capital Partners first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,607 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on 71 West Capital Partners's 13F filing for Q2 2026, filed 4 Aug 2026.